FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

40260211000001109: Tepotinib 225mg tablets 60 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2087401000001112 Tepotinib 225mg tablets 60 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2087421000001117 Tepotinib 225mg tablets 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tepotinib 225mg tablets 60 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has VMP Tepotinib 225mg tablets true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tepotinib false Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has specific active ingredient Tepotinib hydrochloride false Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Tepotinib true Inferred relationship Existential restriction modifier
Tepotinib 225mg tablets 60 tablet Has specific active ingredient Tepotinib hydrochloride true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Tepmetko 225mg tablets (Merck Serono Ltd) 60 tablet Is a True Tepotinib 225mg tablets 60 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start